DexCom, Inc. (LON:0A4M)

London flag London · Delayed Price · Currency is GBP · Price in USD
79.31
-2.38 (-2.91%)
At close: Jun 23, 2025
-2.91%
Market Cap23.95B
Revenue (ttm)3.14B
Net Income (ttm)417.14M
Shares Outn/a
EPS (ttm)1.04
PE Ratio57.42
Forward PE33.76
Dividendn/a
Ex-Dividend Daten/a
Volume88
Average Volume1,889
Open79.31
Previous Close81.69
Day's Range79.31 - 79.31
52-Week Range62.40 - 117.16
Betan/a
RSI49.04
Earnings DateJul 24, 2025

About Exscientia

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 1999
Employees 10,300
Stock Exchange London Stock Exchange
Ticker Symbol 0A4M
Full Company Profile

Financial Performance

In 2024, DexCom's revenue was $4.03 billion, an increase of 11.34% compared to the previous year's $3.62 billion. Earnings were $576.20 million, an increase of 6.41%.

Financial numbers in EUR Financial Statements

News

There is no news available yet.